Genvor, Inc. Publishes Peer-Reviewed Validation of AGM182 Antifungal Peptide Technology
Genvor, Inc. (OTCQB: GNVR), an AI-driven peptide technology company focused on sustainable agriculture, announced the publication of peer-reviewed research validating its proprietary AGM182 antifungal peptide technology.